Table 2.

Cumulative excretion of radioactivity in urine, feces, and residual radioactivity. in carcass after an oral administration of [3H]-labeled Ginsenoside Rb1, Rg1, Rg3s (A), CK, PPD, PPT (B) to the fasted male rats (n = 3/group). The rats were orally administered dosing formulations of 7.4 MBq/kg (radioactivity dose) and 10 mg/kg (ginsenoside Rg1, Rb1, Rg3s, CK, PPD, and PPT doses) once.

	Cumulative excretion of radioactivity (% of dose)
	Time (h)	G- Rb1	G-Rg1	G- Rg3s
(A)
Urine	0–24	0.2 ± 0	1 ± 0.2	0.3 ± 0
	48	0.3 ± 0.1	1.2 ± 0.2	0.4 ± 0.1
	72	0.3 ± 0.1	1.3 ± 0.2	0.5 ± 0.1
	96	0.3 ± 0.1	1.4 ± 0.2	0.5 ± 0.1
Feces	0–24	87.3 ± 1.5	84.7 ± 1.6	75.5 ± 11.7
	48	91.5 ± 0.7	90.3 ± 1	88.1 ± 3.8
	72	91.9 ± 0.7	90.8 ± 0.8	91 ± 1.6
	96	92 ± 0.7	90.8 ± 0.8	91.9 ± 0.3
Carcass	96	0.4 ± 0.1	1 ± 0.3	0.7 ± 0.5
Recovery		92.7 ± 0.6	93.2 ± 0.5	93.2 ± 0.4
	Time (h)	CK	PPD	PPT
(B)
Urine	0–24	0.3 ± 0.1	1.5 ± 0.6	2.6 ± 0.1
	48	0.4 ± 0.2	1.9 ± 0.7	3.2 ± 0.1
	72	0.5 ± 0.2	2.2 ± 0.8	3.8 ± 0.2
	96	0.5 ± 0.2	2.5 ± 0.8	4.2 ± 0.2
	120	0.6 ± 0.2	2.7 ± 0.9	4.4 ± 0.1
	144	0.6 ± 0.3	2.8 ± 0.9	4.7 ± 0.2
	168	0.6 ± 0.3	3 ± 1	4.9 ± 0.2
Feces	0–24	88.5 ± 1.8	79.9 ± 4.1	80.5 ± 2.3
	48	91.6 ± 1.2	87.2 ± 0.4	83.2 ± 0.3
	72	91.9 ± 1.1	87.8 ± 0.6	83.6 ± 0.2
	96	91.9 ± 1.1	88 ± 0.6	83.8 ± 0.2
	120	92 ± 1	88.2 ± 0.6	83.9 ± 0.3
	144	92 ± 1	88.3 ± 0.6	84 ± 0.3
	168	92 ± 1	88.4 ± 0.6	84.2 ± 0.2
Carcass	168	0.5 ± 0.2	2.3 ± 0.4	3 ± 0.5
Recovery		93.2 ± 0.7	93.6 ± 0.7	92.1 ± 0.5

Data are expressed as mean values ± SD (n = 3).